TABLE 1.

Oligonucleotides used in this study

Name	Comment	Sequence
IO-520	ADE5,7	5′-CAACTGCCGTTGTTCATACCGTGACTAATAGTGGCAGTAAGCAGCTTTTTTTTTTTTTCAAAATTTTTCTCGCGCGTTTCGGTGATGACG-3′
IO-521	ADE5,7	5′-ACGGTTAACAGCGGTTGCACTTGCCTCTGAACATAGTTTAAATACCAAGTTCAAGCCCATCGCATAGGCCTGTGCGGTATTTCACACCGC-3′
IO-600	ADE5,7	5′-AACTGCCGTTGTTCATACCGTGACTAATAGTGGCAGTAAGCAGCTTTTTTTTTTTTTCAAAATTTTTCATTTTTTTTTTCAGTTGACTCG-3′
IO-601	ADE5,7	5′-AACTGCCGTTGTTCATACCGTGACTAATAGTGGCAGTAAGCAGCTTTTTTTTTTTTTCAAAATTTTTCATTTTTTTTTTCAGTTGAATTC-3′
IO-602	ADE5,7	5′-GACGGTTAACAGCGGTTGCACTTGCCTCTGAACATAGTTTAAATACCAAGTTCAAGCCCATCGCATATTCATTATTGCTGTTATTACCAG-3′
RO-109	BAS1, 5′	5′-CACGGAATTCTCCAGTCACAGAATAAAGCC-3′
RO-110	BAS1, 5′	5′-CACGAGATCTCATTCTCGATAAAATGTATTCTGCG-3′
RO-111	BAS1, 3′	5′-CACGGGATCCGTTGAGAAGGCAAGGCC-3′
RO-112	BAS1, 3′	5′-CACGGCATGCGCGAGTCATGAAACTACAACG-3′
JO-205	BAS1	5′-GAGCATGATATGACGTCAGGAGGTTCTACCGAGAATGGGTCAGTCCTGCCACTGAATCCT-3′
JO-206	BAS1	5′-GCTTATTACAAAACTAATATGTTAAACAATTGAAAGATTTGTGTTTTTTTTCGGCCTTGC-3′
IO-611	PHO2	5′-GGATGATACGCTCAATTTACTGGATACTACCGTCAACACG-3′
IO-612	PHO2	5′-GATTTATATAAGGACACATGTCTCCACCTATAACGCGAGC-3′
ON275	POL1 ORF	5′-AGAGCTGGTAGAAATGAGTATATCTTAC-3′
ON276	POL1 ORF	5′-TTAGAGCTTGTTGACGAATATCAC-3′
ARN1-5′	ARN1	5′-TGCACCCATAAAAGCAGGTG-3′
ARN1-3′	ARN1	5′-GAGAGCTATCGAATGTTTCC-3′
RO-29	ADE5,7	5′-CGTCCTCGAGCATTTTTTTTTTCAGTTGAC-3′
RO-28	ADE5,7	5′-CGTCCTCGAGGTTCAAGCCCATCGC-3′
IO-301	ADE1	5′-GCCATACTCGAAATTTCAAC-3′
IO-302	ADE1	5′-ACCGTCTTACCTCAAAGAAT-3′
IO-305	ADE2	5′-AGCCGAGAATTTTGTAACAC-3′
IO-306	ADE2	5′-ATGTACTTAGAAGAGAGATC-3′
IO-303	ADE4	5′-ACTATGAACGCTCGTAAGTA-3′
IO-304	ADE4	5′-GAATCTGAAAAGTACAAACC-3′
IO-307	ADE16	5′-CATGTTCTTTTTAGTCGCAC-3′
IO-308	ADE16	5′-TGGATTCTTTGTTTGGAATG-3′
IO-311	HIS4	5′-GCAGAATGCCCCCATCACAA-3′
IO-312	HIS4	5′-CCTTCTATATCGAATGACTG-3′
IO-401	ADE5,7	5′-TTCAGTTGACTCGCCCCGTC-3′
IO-402	ADE5,7	5′-TCCTGGGACGGTTAACAGCG-3′
IO-403	CYC1	5′-CAGTAAATTGACCTGAATAT-3′
IO-404	ADE5,7	5′-GTTCAAGCCCATCGCATATT-3′
ACT-up	ACT1	5′-CTTTCTGGAGGAGCAATGATC-3′
ACT-down	ACT1	5′-GGATTCCGGTGATGGTGTTAC-3′